XKRX:268600 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
6680.00
(0%)
Jan 3
Business Description
Cellivery Therapeutics Inc
ISIN : KR7268600004
Share Class Description:
XKRX:268600: Ordinary SharesCompare
Compare
Traded in other countries / regions
268600.Korea IPO Date
2018-11-09Description
Cellivery Therapeutics Inc is a protein-based drug discovery company operating in the biotechnology industry. It is mainly engaged in developing biotherapeutics capable of entering cells in vivo through proprietary Therapeuticmolecule Systemic Delivery Technology (TSDT).
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -0.97 | |||||
| Debt-to-Equity | -1.75 | |||||
| Debt-to-EBITDA | -14.2 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -14.55 | |||||
| Beneish M-Score | -4.17 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 179.3 | |||||
| 3-Year EBITDA Growth Rate | -9.2 | |||||
| 3-Year EPS without NRI Growth Rate | -40 | |||||
| 3-Year FCF Growth Rate | 23.4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.07 | |||||
| Quick Ratio | 0.05 | |||||
| Days Inventory | 75.75 | |||||
| Days Sales Outstanding | 61.09 | |||||
| Days Payable | 39.75 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.8 | |||||
| Shareholder Yield % | 2.33 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 6.21 | |||||
| Operating Margin % | -83.39 | |||||
| Net Margin % | -69.38 | |||||
| FCF Margin % | 13.1 | |||||
| ROA % | -23.17 | |||||
| ROIC % | -11.49 | |||||
| ROC (Joel Greenblatt) % | -30.34 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 28.19 | |||||
| Price-to-Free-Cash-Flow | 206.15 | |||||
| Price-to-Operating-Cash-Flow | 207.58 | |||||
| EV-to-EBIT | -64.84 | |||||
| EV-to-EBITDA | -118.73 | |||||
| EV-to-Revenue | 33.47 | |||||
| EV-to-FCF | 255.45 | |||||
| Earnings Yield (Greenblatt) % | -1.54 | |||||
| FCF Yield % | 0.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cellivery Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 8,831.442 | ||
| EPS (TTM) (â‚©) | -163 | ||
| Beta | 0.07 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (â‚©) | 0 | ||
| 20-Day SMA (â‚©) | 6680 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (â‚©) | 6680 - 6680 | ||
| Shares Outstanding (Mil) | 37.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cellivery Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cellivery Therapeutics Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cellivery Therapeutics Inc Frequently Asked Questions
What is Cellivery Therapeutics Inc(XKRX:268600)'s stock price today?
The current price of XKRX:268600 is â‚©6680.00. The 52 week high of XKRX:268600 is â‚©6680.00 and 52 week low is â‚©6680.00.
When is next earnings date of Cellivery Therapeutics Inc(XKRX:268600)?
The next earnings date of Cellivery Therapeutics Inc(XKRX:268600) is .
Does Cellivery Therapeutics Inc(XKRX:268600) pay dividends? If so, how much?
Cellivery Therapeutics Inc(XKRX:268600) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers